Literature DB >> 28397868

Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.

S H Han, S-H Kim, H-J Kim, Y Lee, S-Y Choi, G Park, D-H Kim, A Lee, J Kim, J-M Choi, Y Kim, K Myung, H Kim, D-W Kim.   

Abstract

This corrects the article DOI: 10.1038/leu.2017.107.

Entities:  

Year:  2017        PMID： 28397868     DOI： 10.1038/leu.2017.107

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


  4 in total

1.  COBLL1 modulates cell morphology and facilitates androgen receptor genomic binding in advanced prostate cancer.

Authors:  Ken-Ichi Takayama; Takashi Suzuki; Tetsuya Fujimura; Satoru Takahashi; Satoshi Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-23       Impact factor: 11.205

2.  Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B.

Authors:  Alfonso E Bencomo-Alvarez; Andres J Rubio; Idaly M Olivas; Mayra A Gonzalez; Rebecca Ellwood; Carme Ripoll Fiol; Christopher A Eide; Joshua J Lara; Christian Barreto-Vargas; Luis F Jave-Suarez; Georgios Nteliopoulos; Alistair G Reid; Dragana Milojkovic; Brian J Druker; Jane Apperley; Jamshid S Khorashad; Anna M Eiring
Journal:  Oncogene       Date:  2021-03-12       Impact factor: 9.867

3.  FAM167A is a key molecule to induce BCR-ABL-independent TKI resistance in CML via noncanonical NF-κB signaling activation.

Authors:  Taewoo Yang; Kyu-Young Sim; Gwang-Hoon Ko; Jae-Sook Ahn; Hyeoung-Joon Kim; Sung-Gyoo Park
Journal:  J Exp Clin Cancer Res       Date:  2022-03-03

4.  Genetic Profiling in Children With Acute Lymphoblastic Leukemia Referred for Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Kinga Kwiecinska; Wojciech Strojny; Miroslaw Bik-Multanowski; Marcin Piechota; Walentyna Balwierz
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.